Caroline O'Leary

Specialist Medical Oncology Registrar in Ireland

[Caroline O'Leary @colearyirl]

Very proud of publication of our review article of immune-related toxicity in NSCLC in JTO. It includes systematic review of common/severe toxicities and future directions
Huge thanks to @DrJNaidoo @JTOonline and my co-authors for all the help and support

https://t.co/6yF5eGQlWO

[Jarushka Naidoo @DrJNaidoo]

Wonderful to have @peters_solange present 10yrs of progress in immunotherapy, & the🇨🇭experience of how to develop & maintain clinical trials:

- support PIs (time, local leadership)
- trials unit staffing
- industry/academic trial balance

@cancertrials_ie @etop_ibcsg #LCSM

[Patrick Forde @FordePatrick]

Congratulations to my colleague & friend Prof. @DrJNaidoo from @RCSI_Irl @CancerCentreIre co-leading one of the largest cancer conferences worldwide now on in Barcelona, she is proudly representing 🇮🇪 globally! @IrishCancerSoc @cancertrials_ie @IASLC

[Dr Ciara McNevin @csmcnevin]

We’ve launched a pilot registry @stjamesdublin for patients with cancer-predisposing genetic alterations but Ireland deserves a national registry!

If you have one of these alterations, please complete our PPI survey: https://t.co/vLMSSvnvkI

⭐Every response matters⭐

[Jarushka Naidoo @DrJNaidoo]

#ESMOAcademy25
Irish oncology trainees🇮🇪 in full force at the ESMO academy in Prague🇨🇿 thanks @myESMO for putting together this super educational event in preparation for the ESMO exam, with over 300 participants from 40+ countries!

@CancerCentreIre @RCSI_Irl @RCPI_Trainees

[Caroline O'Leary @colearyirl]

Amazing venue for the 2025 ESMO Academy in Prague, with some familiar faces contributing to the excellent learning @myESMO @DrJNaidoo

[Caroline O'Leary @colearyirl]

Amazing #ASCO2025 and especially privileged to watch friends and mentors present new outstanding and inspiring work that we will be talking about, and hopefully utilising, for a long time to come

[Patrick Forde @FordePatrick]

~13yrs of neoadjuvant adventure comes to positive conclusion (for now)! In @NEJM today & presented at #ASCO25 5 yr survival for pts w lung cancer that can be removed by surgery is better with just 3 doses of immunotherapy before the operation! https://t.co/RS4urrH1UB #LCSM 1/

[Stephen V Liu, MD @StephenVLiu]

Dr. @FordePatrick presents final OS results from CheckMate 816 at #ASCO25. Adding nivolumab to 3 cycles of neoadjuvant chemotherapy for resectable NSCLC improves OS with HR 0.72 and 5y OS rate 65% vs 55%. Effect greater in PDL1+ (HR 0.51) than PDL1 negative (HR 0.89).

[ProfJohnCrown @ProfJohnCrown]

Dr Sarah Lochrin on the #ASCO25 #ASCO 2025 podium where she delivered a great talk on single cycle neo-adjuvant ipilimumab +nivolumab in melanoma. Dr Lochrin will
be joining us as consultant oncologist in SVH later this year.

[Audrey O'Halloran @AudreyOHalloran]

🤩 Amazing work from Louise Kelly and the young onset cancer team @stjamesdublin @CancerInstIRE presenting their fantastic poster @ASCO on 'Sexual health communication and young onset cancer healthcare practitioners attitudes and practices' #ASCO25 #SJHCancerNursing #SJHMDT #ICS

[Emily Harrold @EmilyHarrold6]

Wonderful to see Irish fellows on the podium @ASCO discussing novel preoperative approaches @RonanAndrewMcL1 @LochrinSarah

[Grainne O'Kane @graokane]

🔥NeoPancOne🇨🇦
➡️mFFX in resectable PDAC
➡️exploring GATA6&subtypes
➡️mEFS &OS 16.3 &34.2mths
➡️1yr EFS 90% in GATA6 hi vs 50% lo
➡️1yr OS classical 95% vs.57% basal-like
⭐️Time to subtype upfront in all PDAC recognising plasticity @OncoAlert #ASCO25 @OICR_news @pmcancercentre

[Seamus O’Reilly MD PhD @Seamusoreilly18]

Please support @IrishCancerSoc on 🌼 day today, they have been pivotal in supporting ☘️ @cancertrials_ie studies and 👩‍🔬 cancer research 🔬shown here 👇

[Trinity St James's Cancer Institute @CancerInstIRE]

We @CancerInstIRE know the importance of providing holistic cancer care for patients, as Paul says cancer touches the whole family. With our partnership with @IrishCancerSoc our Young Onset Cancer programme provides such supports working towards comprehensive cancer care

[Patrick Forde @FordePatrick]

Nice work led by Dr. @CEochagain @CancerInstIRE @TrinityMed1

[Dr Anne-Marie Baird @BairdAM]

Momentous day at @officialgaa HQ with the launch of the @CancerCentreIre @IrishCancerSoc Lung Health Check led by @DrJNaidoo Dan Ryan & Patrick Redmond. Very emotional to see the mobile scanner 🫁 @CotterSeamus & I are the steering committee patient advocates #ScreeningSavesLives

[Jarushka Naidoo @DrJNaidoo]

Long-Term Toxicity of Immune Checkpoint Inhibitors @JAMAOnc

Here, our stellar fellow @ChrisCronin1 charts a roadmap of how to quantitate the nuanced toxicities of IO- from irAEs to time toxicity- towards IO survivorship

@CancerCentreIre @OncoAlert #LCSM
https://t.co/uTvjpPTnC5

[Dr Ciara McNevin @csmcnevin]

Delighted to share that our paper has been published investigating the prevalence of mismatch repair in early prostate cancer https://t.co/1tFeoMXbAf @CancerInstIR @CCR_AACR @stjamesdublin @tcddublin @StephenFinn @BairdAM @ICATProgramme @RCPI_news

[The BMJ @bmj_latest]

"How can leaders make evidence informed decisions if there is no evidence?"

A US researcher in the federal system talks about what the past few weeks have been like, as data have been pulled and colleagues put on administrative leave
https://t.co/X95F47M1fT

[John McCaffrey @crashimminent]

Neoadjuvant session across five cancer types ongoing at Gathering around Cancer Dublin 2024